These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8223761)

  • 1. The arrhythmogenic substrate--diagnostic and therapeutic implications: hypertrophic cardiomyopathy.
    Slade AK; Saumarez RC; McKenna WJ
    Eur Heart J; 1993 Sep; 14 Suppl E():84-90. PubMed ID: 8223761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Slade AK; Camm AJ
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():37-49. PubMed ID: 8734163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Fananapazir L
    Circulation; 1992 Jan; 85(1 Suppl):I57-63. PubMed ID: 1728506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular arrhythmias complicating hypertrophic cardiomyopathy.
    Hutchings D; Sankaranarayanan R; Venetucci L
    Br J Hosp Med (Lond); 2012 Sep; 73(9):502-8. PubMed ID: 23124402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death.
    Chang AC; McAreavey D; Fananapazir L
    Curr Opin Cardiol; 1995 Jan; 10(1):9-15. PubMed ID: 7787270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuro-cardiac interaction in malignant ventricular arrhythmia and sudden cardiac death.
    Ng GA
    Auton Neurosci; 2016 Aug; 199():66-79. PubMed ID: 27423297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmia and hypertrophic cardiomyopathy.
    Shakespeare CF; Keeling PJ; Slade AK; McKenna WJ
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():31-6. PubMed ID: 1307192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeled left ventricular myocardium remote to infarction sites is the arrhythmogenic substrate for sudden cardiac death.
    Tsai CF; Ueng KC; Wu DJ; Tsai TP; Lin CS
    Med Hypotheses; 2010 Oct; 75(4):368-71. PubMed ID: 20399566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducibility of life-threatening ventricular arrhythmias is related to maximum left ventricular thickness and clinical markers of sudden cardiac death in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Hedman A; Hartikainen J; Vanninen E; Laitinen T; Jääskeläinen P; Laakso M; Peuhkurinen K; Kuusisto J
    J Mol Cell Cardiol; 2004 Jan; 36(1):91-9. PubMed ID: 14734051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?].
    Grobéty M; Schlaepfer J; Kappenberger L; Fromer M
    Schweiz Med Wochenschr; 1997 Apr; 127(15):623-30. PubMed ID: 9198888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of cardiac arrhythmia in patients with hypertrophic cardiomyopathy].
    Wang Y; Cui YH; Wang DW
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):401-4. PubMed ID: 15061995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia.
    Wolf CM; Moskowitz IP; Arno S; Branco DM; Semsarian C; Bernstein SA; Peterson M; Maida M; Morley GE; Fishman G; Berul CI; Seidman CE; Seidman JG
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18123-8. PubMed ID: 16332958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syncope and ventricular arrhythmias in hypertrophic cardiomyopathy are not related to the derangement of coronary microvascular function.
    Lorenzoni R; Gistri R; Cecchi F; Olivotto I; Chiriatti G; Elliott P; McKenna WJ; Camici PG
    Eur Heart J; 1997 Dec; 18(12):1946-50. PubMed ID: 9447323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Cecchi F; McKenna WJ
    Br Heart J; 1994 Dec; 72(6 Suppl):S13-8. PubMed ID: 7873317
    [No Abstract]   [Full Text] [Related]  

  • 18. Sudden unexpected death in young athletes: reconsidering "hypertrophic cardiomyopathy".
    Rowland T
    Pediatrics; 2009 Apr; 123(4):1217-22. PubMed ID: 19336382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline fragmented QRS increases the risk of major arrhythmic events in hypertrophic cardiomyopathy: Systematic review and meta-analysis.
    Rattanawong P; Riangwiwat T; Kanitsoraphan C; Chongsathidkiet P; Kanjanahattakij N; Vutthikraivit W; Chung EH
    Ann Noninvasive Electrocardiol; 2018 Jul; 23(4):e12533. PubMed ID: 29363882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy.
    Müller G; Ulmer HE; Hagel KJ; Wolf D
    Pediatr Cardiol; 1995; 16(2):56-60. PubMed ID: 7540289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.